SCHEMBL4075807

SCHEMBL4075807

CC(C)(C=O)CNCCCC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 1/20 0.37
LMNA P02545 2/20 0.37
SLC22A6 Q4U2R8 2/20 0.37
TSHR P16473 3/20 0.36
S1PR1 P21453 2/20 0.36
S1PR3 Q99500 2/20 0.36
S1PR2 O95136 1/20 0.36
HDAC11 Q96DB2 2/20 0.36
NR1H4 Q96RI1 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10247191 0.82 LMNA (0.42) ADRA1ALMNASLC22A6TSHRS1PR1
SCHEMBL2421572 0.76 ADRA1A (0.48) ADRA1ALMNASLC22A6TSHRHDAC11
SCHEMBL26861624 0.75 LMNA (0.43) LMNASLC22A6TSHRHDAC11NFKB1
SCHEMBL7469077 0.75 ADH1B (0.44) TSHRS1PR1S1PR3S1PR2HDAC3
SCHEMBL28417400 0.74 LMNA (0.48) LMNASLC22A6TSHRHDAC11NFKB1
Adipic Acid SCHEMBL30173234 0.74 LMNA (0.48) LMNASLC22A6TSHRHDAC11NFKB1
SCHEMBL28818283 0.74 LMNA (0.42) ADRA1ALMNASLC22A6TSHRS1PR1
SCHEMBL112741 0.73 LMNA (0.59) ADRA1ALMNASLC22A6TSHRHDAC11
SCHEMBL28084746 0.72 TSHR (0.50) LMNASLC22A6TSHRHDAC11NFKB1
SCHEMBL9936340 0.72 EPHX1 (0.50) TSHRS1PR1S1PR3S1PR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101585-A1 DIALKYLAMINO ALKYL ESTERS OF PIVAGABINE AS MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Cenerx Biopharma, Inc. (US) 2009-09-23 EP disclosed
WO-2008141112-A1 METHODS OF TREATING RETT SYNDROME CENERX BIOPHARMA, INC. (US) 2008-11-20 WO disclosed
WO-2008066874-A1 DIALKYLAMINO ALKYL ESTERS OF PIVAGABINE AS MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS CENERX BIOPHARMA, INC. (US) 2008-06-05 WO disclosed